PET/CT in Disease Detection and Follow-up of Subcutaneous Involvement in Marginal Zone Lymphoma
Positron emission tomography/computed tomography (PET/CT) has important value in staging of many non-Hodgkin lymphoma histologies; however, its role in assessment of marginal zone lymphoma (MZL) is controversial. Evaluation of 571 PET/CT scans of 178 patients with MZL revealed subcutaneous lesions in 11% of patients. We characterized their unique and specific PET/CT findings that enhance clinical diagnosis, accurate staging, and follow-up of MZL.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tima Davidson, Abraham Avigdor, Yakov Oksman, Ella Nissan, Maya Zlotnick, Bar Chikman, Johnatan Nissan, Elinor Goshen, Simona Ben-Haim, Ohad Benjamini Tags: Original Study Source Type: research
More News: CT Scan | Hematology | Hodgkin's Disease | Leukemia | Lymphoma | Myeloma | Non-Hodgkin's Lymphoma | PET Scan | Study